KRISTINA HOSEK: Open Payments
NPI 1053716951 · FLORESVILLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$475 in 24 payments from 9 companies in 2025. Trend: 2023 $427 · 2024 $274 · 2025 $475
Food & beverage: $475
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $256 |
| Lilly USA, LLC | 2 | $54 |
| Amgen Inc. | 2 | $43 |
| Exact Sciences Corporation | 2 | $37 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| Novo Nordisk Inc | 1 | $18 |
| Phathom Pharmaceuticals, Inc. | 1 | $15 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
Products named: VRAYLAR, UBRELVY, QULIPTA, MOUNJARO, OTEZLA, Cologuard Collection Kit, REXULTI, Rybelsus.
Industry payments across TX — which companies pay providers there.
